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Abstract 
Background: Rodent behavioural assays are widely used to delineate the 
mechanisms of psychiatric disorders and predict the efficacy of drug candidates. 
Conventional behavioural paradigms are restricted to short time windows and 
involve transferring animals from the homecage to unfamiliar apparatus which 
induces stress. Additionally, factors including environmental perturbations, handling 
and the presence of an experimenter can impact behaviour and confound data 
interpretation. To improve welfare and reproducibility these issues must be 
resolved. Automated homecage monitoring offers a more ethologically relevant 
approach with reduced experimenter bias.  
Aim: To evaluate the effectiveness of an automated homecage system at detecting 
locomotor and social alterations induced by phencyclidine (PCP) in group-housed 
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rats. PCP is an NMDA receptor antagonist commonly utilised to model aspects of 
schizophrenia.  
Methods: Rats housed in groups of 3 were implanted with radio frequency 
identification (RFID) tags. Each homecage was placed over a RFID reader baseplate 
for the automated monitoring of the social and locomotor activity of each individual 
rat. For all rats, we acquired homecage data for 24 h following administration of 
both saline and PCP (2.5 mg/kg).  
Results: PCP resulted in significantly increased distance travelled from 15 to 60 min 
post injection. Furthermore, PCP significantly enhanced time spent isolated from 
cage-mates and this asociality lasted from 60 to 105 min post treatment.   
Conclusions: Unlike conventional assays, in-cage monitoring captures the temporal 
duration of drug effects on multiple behaviours in the same group of animals.  This 
approach could benefit psychiatric preclinical drug discovery though improved 
welfare and increased between-laboratory replicability.   
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Introduction 
Rodent behavioural assays are used extensively to gain insights into disease 
mechanisms and predict the efficacy of putative treatments. A wealth of paradigms 
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are available to assess a broad range of behaviours including sensorimotor function, 
sociability, depression, anxiety and cognition (Wahlsten, 2011; Crawley, 2007). 
However, conventional behavioural assays have several limitations that may impact 
welfare and replicability (Kafkafi et al., 2018). Firstly, testing often involves 
separating the animal from its cage-mates and placing it in an unfamiliar apparatus; 
however disrupting a rodents social environment causes stress- associated 
behavioural, hormonal and neurochemical changes that could confound data 
interpretation (Ferland & Schrader, 2011; Beery & Kaufer, 2015; Ieraci et al., 2016). 
Furthermore, for the same behavioural task, phenotypic outcome can vary 
depending on the laboratory environment, experimenter identity and 
handling/habituation techniques utilised (Chesler et al., 2002; Sorge et al., 2014; 
Wahlsten et al., 2003; van Driel and Talling, 2005; Gouveia & Hurst, 2017). For 
convenience, behavioural assessments are often conducted during the light period 
which represents the natural resting phase for rodents; however, animals are less 
susceptible to stress when tested in the dark (Kelliher et al., 2000; Hawkins & 
Golledge, 2018; Aslani et al., 2014). Many assays focus on a discrete behavioural 
domain, however when examining drug effects, multiple interacting behaviours with 
distinct temporal profiles can occur leading to potentially skewed conclusions and 
an incomplete understanding of the profile of action. To improve animal welfare, 
obtain more reliabile reproducible results, and gain richer data sets, it is important 
to resolve the above issues (Kafkafi et al., 2018).  
Recent emphasis has been placed on the development of automated homecage 
systems for more ethologically relevant testing and reduced experimenter bias 
(Richardson, 2015; Richardson, 2012). Unlike conventional assays, automated 
approaches permit continual monitoring for days to weeks, even during the dark 
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phase and they reduce the requirement for handling which is a source of stress and 
outcome variation (Hurst & West, 2010; Gouveia & Hurst, 2017). Several homecage 
technologies are available for the automated tracking of locomotor activity, 
circadian rhythmicity, social interactions and feeding behaviour (de Visser et al., 
2006; Clemmensen et al., 2015; Freund et al., 2013; Vannoni et al., 2014; 
Galsworthy et al., 2005; Morretti et al., 2005; Robinson & Riedel, 2014). However, 
many of the existing systems involve bespoke semi-natural environments and they 
have limited scope for acquiring the social activity of more than two animals (see 
Bains et al., 2018 for a review). Objective assays for monitoring social behaviours 
are crucial for screening therapeutic candidates for a range of neuropsychiatric 
disorders including schizophrenia and autism (Mier and Kirsch, 2017; Worley & 
Matson, 2012). Traditionally, sociability is assessed by hand-scoring encounters 
between pairs of rodents in an arena (or homecage); complex interactions (e.g. 
allogrooming, pouncing, wrestling) can be measured but manual scoring is laborious, 
often limited to a short (~10 min) window and subject to experimenter bias (Himmler 
et al., 2013; Lee et al., 2005; Boulay et al., 2004; Sato et al., 2004; Paasonen et al., 
2017; Cox & Rissman, 2011). Another technique involves utilising a 3-chambered 
arena and measuring the length of time a rodent spends in the chamber containing 
a caged conspecific; this task can be automated for an objective high throughput 
approach but testing is often restricted to a 5-10 min trial performed under bright 
lighting (Moy et al., 2013; Nadler et al., 2004; McKibben et al., 2014; Hanks et al., 
2013).  
ActualHCATM (Actual Analytics, UK) was developed as part of the “Rodent Big 
Brother” project funded by the National Centre for the Replacement, Reduction and 
Refinement of Animals in Research, UK (NC3Rs) to continually monitor multiple 
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rodents within the homecage in the absence of invasive surgery (Bains et al., 2016). 
This technology is compatible with conventional individually ventilated caging (IVC) 
and capable of collecting spatial data for each individual animal within the cage 24 
h per day without experimenter intervention. ActualHCATM permits individual 
locomotor, social and temperature data to be acquired from group-housed animals 
across days to weeks (Redfern et al., 2017; Bains et al., 2016; Bains et al., 2018). In 
rats, ActualHCATM can accurately detect alterations in locomotion and temperature 
induced by sedative and stimulant agents (chlorpromazine,  clonidine and 
amphetamine) (Tse et al., 2018). However, it is yet to be established whether 
ActualHCATM can detect social changes induced by a pharmacological agent.  
Here, in groups of Lister-Hooded rats, we explored the effectiveness of ActualHCATM 
at detecting behavioural deficits associated with phencyclidine (PCP). NMDA 
receptor hypofunction is implicated in the pathogenesis of schizophrenia and 
accordingly, NMDA receptor antagonists including PCP are widely used to model 
aspects of schizophrenia in animals (Pratt et al 2012; Pratt et al., 2018; Morris et 
al., 2005; Jones et al., 2011). Our main objective was to validate the ability of 
ActualHCATM to accurately detect the locomotor and social effects of PCP and 
establish the temporal profiles of these behaviours. In addition, we investigate the 
possibility that PCP impacts circadian activity.  We propose that utilisation of the 
ActualHCATM system in concurrence with conventional assays may facilitate 
preclinical drug discovery via improved animal welfare, increased data 
reproducibility and the provision of richer data sets that permit simultaneous 
assessment of a range of behaviours. 
Materials and methods 
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Ethical Statement 
All procedures were approved by the Animal Welfare and Ethical Review Body of the 
University of Strathclyde and were conducted in accordance with the Animal 
Scientific Procedures Act, 1986 (Project Licence PPL 60/4463 to Dr Thomson). The 
ARRIVE guidelines were utilised in the execution and reporting of this experiment 
(Kilkenny et al., 2010).  
 
Animals, housing and husbandry 
15 male Lister-Hooded rats (Charles River Laboratories, Margate, UK; aged 40 to 58 
days during data acquisition) were housed in groups of 3 in IVC cages (Tecniplast, 
Buguggiate, Italy) for 1 week before experimentation commenced. Cages contained 
a 1-1.5 cm layer of Aspen chip bedding along with sizzle nesting and chew bricks 
(Datesand, UK) for environmental enrichment. Rats were maintained under a 12 h 
light/dark cycle (lights on at 06:00) with food and water available ad libitum. 
Monitoring of health and well-being was performed daily during husbandry 
procedures.  
Microchip implantation 
Rats were briefly anaesthetised with isoflurane in 100% oxygen (Baxter Healthcare 
Ltd, UK: 4% for chamber induction; 1-2% for facemask maintenance). The metacarpal 
region of the hind-foot was pinched to confirm appropriate depth of anaesthesia 
then a radio frequency identification (RFID; BIO13.THERM.03V1; Biomark Inc., USA) 
tag was inserted subcutaneously into the lower right abdominal quadrant using a 
sterile implant device (a modified syringe supplied by the RFID manufacturer). Rats 
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were then returned to their homecages and allowed to recover from the 
microchipping procedure for 3 days prior to data acquisition. There were no welfare 
issues associated with the implantation.  
The ActualHCATM system  
The ActualHCATM system is described in detail elsewhere (Redfern et al., 2017). 
Briefly, an IVC cage was positioned on top of an RFID reader baseplate (with 12 
antennae in a 3 x 4 array) for automated acquisition of the spatial location of each 
individual rat. A side-mounted camera allowed for continuous video capture (day 
and night). Health status checks were performed daily (9am). The software package 
ActualHCA-Capture (Actual Analytics Ltd, UK) collected baseplate data to provide 
the following measures for each individual animal (in 5 and 15 min segments): 
distance travelled (mm) and time spent isolated (> 200 mm) from all other cage-
mates (s). A value of >200mm was selected to reflect isolation time according to 
previous studies using conventional social interaction tests (Sams Dodd 1996;1998)  
A second software package, ActualHCA Analysis tool v 2.2.2 (Actual Analytics Ltd, 
UK), was utilised to overlay videos with baseplate rat location data such that 
individual rats could be identified during manual behavioural scoring.  
Drug administration and data acquisition 
Drug administration was performed according to Procedures With Care guidelines  
(procedureswithcare.org.uk). For each rat, we collected ActualHCATM data for 24 h  
following both saline (0.9% NaCl) and PCP (2.5 mg/kg dissolved in 0.9% NaCl)  
administration (within subjects design).  Each rat within a homecage of 3 animals 
received the same treatment regime whereby saline was administered followed by 
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PCP 48 h later. We selected a PCP dose of 2.5 mg/kg based on our previous data 
and reports of deficits in conventional locomotor and social assays (Egerton et al., 
2005; Adams et al., 2013; Sturgeon et al., 1979; Paasonen et al., 2017). Injections 
were performed 15 min prior to the onset of the dark period (17:45; 
intraperitoneal (IP), 4 ml/kg injection volume) in order to capture drug effects 
when rats are typically most active. and Animals sharing a cage were administered 
the same treatment on the same day. To verify PCP – induced social deficits, 
conventional manual scoring of interactions (pouncing, pinning, allo-grooming, 
boxing and wrestling) was performed using ANVIL software (v5.1.9, Kipp) on video 
footage acquired 0 to 60 min following saline/PCP administration. The 
experimenter was blinded to treatment groups during manual scoring.   
Statistical analysis 
Drug effects on automated ActualHCATM data were explored via repeated measures 
ANOVA with treatment, cage and time as factors (with each individual subject 
nested within its cage number) followed by Fisher’s post-hoc testing (Minitab v.18.1 
(State Collegue, PA, USA). Drug effects on manual social observations were explored 
via paired t-tests.  
 
Results 
Effect of PCP on locomotor activity  
Figure 1(a) and Figure 1(b) show distance travelled per 5 min bin across 24 h 
following saline and PCP treatment, respectively, for a single randomly selected rat. 
A striking burst of hyperactivity was observed immediately following PCP 
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administration and this phenotype lasted for approximately 1 h. Apart from the 
initial burst of hyperlocomotion, the activity profile of PCP was remarkably similar 
to that of saline. Figure 1(c) shows distance travelled per 15 min bin across 24 h 
following saline (and PCP) treatment for all rats (mean ± SEM). There were 
significant main effects of treatment (F (1, 2870) = 6.49; p = 0.011 p<0.05), 
dark/light period (F (1, 2870) = 811.67; p < 0.0001) and time (F (94, 2870) = 16.47; 
p < 0.0001) and a treatment by time interaction (F (94, 2870) = 3.84; p < 0.0001). 
According to Fisher’s post-hoc analysis, PCP treated rats were hyperactive from 15 
to 60 min post injection (p<0.05) (Figure 1(d)). We also found evidence of 
hypoactivity in PCP-treated rats at 3 h post injection (p<0.01) (Figure 1(e)) which 
may represent a recovery period following locomotor stimulation. PCP treated rats 
exhibited a brief bout of hyperactivity at 6 h post treatment (p<0.0001) (Figure 
1(e)). Additionally, PCP-treated rats showed significantly reduced activity 1 h prior 
to the light period (p < 0.01) and 45 to 60 min after the light period onset (p<0.001) 
(Figure 1(f)) which could reflect a subtle drug effect on circadian rhythmicity. 
Finally there was a short bout of hypoactivity in PCP-treated rats at 16 h post 
administration (p < 0.01).  
In summary, there was a marked short-lived PCP-induced hyperactivity of lasting 
~1hour followed by periods of hypoactivity particularly just prior to and following 
the onset of the light period (~12h post drug administration). 
Effect of PCP on social activity 
Figure 2 (a) shows time spent isolated (> 200 mm) from all cage-mates (s) per 15 
min bin over 24 h following treatment for all rats (mean ± SEM). There were 
significant main effects of treatment (F (1, 2870) = 30.33; p = 0.0001 p<0.001), 
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dark/light period (F (1, 2870) = 32.37; p < 0.0001) and time (F (94, 2870) =1.38; p < 
0.01) and a treatment by time interaction (F (94, 2870) = 2.06; p < 0.0001). PCP-
treated rats spent significantly more time in isolation compared to saline-treated 
rats from 60 to 105 min post injection (p < 0.05, Fisher’s post-hoc) (Figure 2(b)). We 
also obtained evidence of significantly increased isolation in PCP-treated rats from 
5 to 7.5 h post treatment (Figure 2(c)) and during the light/dark transition phase 
(Figure 2 (d)). 
Using conventional manual scoring, we verified PCP – induced asociality whereby 
rats exhibited significant reductions in time spent allogrooming, pouncing and 
pinning compared to those treated with saline (Table 1) during the first hour post 
injection.   
  
 
 
Treatment 
Behaviour Sal PCP 
Allogrooming 24.36 ± 5.87 4.68 ± 4.59**** 
anogenital sniffing 3.01 ± 1.14 0.66 ± 0.27 
Pinning 13.83 ± 3.85 0.42 ± 0.28*** 
Pouncing 4.05 ± 0.75 0.43 ± 0.28** 
Total 45.31 ± 6.70 6.19 ± 4.72**** 
 
Table 1. Effect of PCP on manually scored social interactions occurring 0 to 60 min 
post injection. **p<0.01, ***p<0.001, ****p<0.0001 (paired t-test). N = 15 per group. Data 
represent mean ± SEM for time (s) engaged in behaviour.  
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Discussion 
Automated homecage analysis allows multiple behaviours to be acquired 
simultaneously thereby minimising the confounding influences of environmental 
perturbations or the presence of an experimenter. In the current study, ActualHCATM 
detected both hyperactivity and social isolation in rats following an acute injection 
of PCP; such deficits are consistent with the known pharmacological profile of PCP 
in rats. Thus, our findings support the use of ActualHCATM as a sensitive screening 
approach for pharmacological agents. This technology could contribute to 
improvements in drug discovery through increased reproducibility of data, detection 
of the concurrent temporal profile of behaviours as well as reduced and refined 
animal use.  
PCP- induced hyperactivity  
Traditionally, drug effects on locomotion are examined by placing a single animal in 
an open-field (or bespoke cage) for a limited duration and quantifying its movements 
either automatically (e.g. video tracking or infrared beams) or manually (e.g. hand-
scoring of line crossings). Using such assays, acute administration of a low dose of 
PCP has been shown to result in hyperactivity in rodents and this phenotype is 
frequently used to model positive symptoms of schizophrenia (Pratt et al., 2012; 
2018; Balu et al., 2016). Here, automated analysis allowed us to evaluate the 
locomotor effects of PCP over 24 h and, apart from brief restraint for drug 
administration, rats remained undisturbed in their familiar homecage and social 
groups. PCP administration at 2.5 mg/kg induced a rapid increase in locomotor 
activity that reached maximum level 15 min post treatment and persisted for 60 
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min.   This finding is consistent with results from open-field studies, showing that a 
dose of 2.5 mg/kg produces peak hyperactivity between 15 to 60 min (Adams et al., 
2013) and between 5 and 75 min (Sturgeon et al., 1979). Unlike conventional out-
of-cage locomotor assays, homecage analysis permitted a 24 h profile of PCP. At 3 h 
post PCP injection, rats were hypoactive for 45 min which may reflect a recovery 
period following locomotor stimulation. PCP-treated rats were also hypoactive 
during the dark/light transition phase, suggestive of altered circadian activity.  
In summary, we demonstrate a marked short-lived PCP-induced locomotor 
hyperactivity post injection in line with previous work. Interestingly, the extended 
evaluation of behaviour in the homecage monitoring system, revealed periods of 
hypoactivity, 3h post drug and also at later time points.  The significance of these 
longer term reductions in locomotor activity is unclear, but a possible PCP-induced 
disruption of circadian rhythms warrants further investigation. 
Other homecage systems utilised for the automated acquisition of rodent locomotor 
activity include PhenoRack (Aniszewska et al., 2014), LABORAS (Goulding et al., 
2008), Phenotyper (de Visser et al., 2006; Loos et al., 2014), PhenoMaster 
(Edelsbrunner et al., 2009; Clemmensen et al., 2015) and Intellicage (Krackow et 
al., 2010; Galsworthy et al., 2005). The Phenotyper and Intellicage are effective at 
detecting locomotor inhibitory effects of apomorphine, and the Phenotyper can 
detect decreased activity associated with a high dose of PCP (Robinson & Riedel, 
2014). However, apart from Intellicage, existing automated systems require animals 
to be solitary housed. Intellicage permits up to 16 animals per cage, deriving 
locomotor output from frequency of visits to water bottle corners (as opposed to 
absolute distance travelled) once animals have been habituated to its bespoke 
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environment. In contrast, ActualHCATM offers the ability to discriminate distance 
travelled for individual animals housed in groups in the homecage itself. In 
summary,when compared to other systems, the  ActualHCATM offers an advantage in 
that drug-induced behaviours in group housed animals in a homecage can be 
monitored. For the first time we have shown the temporal profile of low dose PCP- 
induced locomotor hyperactivity and social behaviours in an automated system 
where animals are not solitary housed.     
PCP- induced social isolation 
Rodent social paradigms typically involve placing unfamiliar pairs of rodents in a 
novel environment (e.g. an open field or 3-chambered arena) and capturing their 
interactions for a brief time window either manually or with tracking software. In 
rats, a low dose of PCP reduces social interactions (e.g. sniffing, allogrooming) and 
time spent in proximity to a caged conspecific and these deficits are often claimed 
to be relevant to negative symptoms of schizophrenia (Sams-Dodd 1996; Guruajan 
et al., 2010; Wilson & Koenig, 2013) but arguably are also relevant to social cognition 
deficits (Millan and Bales 2013). In-cage monitoring allowed us to examine the social 
effects of PCP across an extended period of time without separating rats from their 
cage-mates or removing them from their homecage. For the first time, using this 
technology, we observed a disruption of social interaction at 60 to 105 min post 
administration of 2.5 mg/kg PCP. We also found bouts of increased isolation 
throughout the dark period and early light period. Previous studies which measure a 
‘snapshot’ of behaviour (~10 min), demonstrated reduced pairwise interactions 
between rats in an arena 45 min after 1.5 mg/kg (Paasonen et al., 2017) and 30 min 
after 1 mg/kg (Boulay et al., 2004) PCP administration. Notably at these time points 
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hyper locomotor activity may be a potential confound in the interpretation of the 
social data. Intriguingly, the minimum dose of PCP required to disrupt social 
approach in the 3-chamber task was reported to be 5 mg/kg (McKibben et al., 2014). 
Therefore the spontaneous interactions observed in the homecage may offer a 
greater sensitivity than some conventional assays to detect subtler social effects 
associated with low drug doses. Nevertheless, further optimisation of the automated 
home cage monitoring system is important since at present, algorithms that enable 
distinct elements of social behaviour such as allogrooming and pinning to be 
determined automatically are in the early stages of development. 
In summary, we observed PCP-induced deficits in social behaviours using automated 
measures of social isolation and manually scored measures of sociability.  An 
advantage of automated measures is that it permits behavioural analysis for longer 
time periods (days rather than minutes) and reduces the labour-intensive process of 
manual recordings which are also subject to experimenter bias. Furthermore, 
automated recordings, are made in group housed animals in a home cage, providing 
a more ethological based-analysis of social behaviours than the classic social 
interaction and 3 chamber test where animals are separated from their cage mates.  
A key finding of the present data was the distinct temporal trajectories of PCP-
induced changes in hyperactivity and social deficits, but which overlapped at 60 min 
post PCP treatment.   Importantly, the social isolation induced by PCP outlasted the 
hyperactive phenotype by ~45 min, supporting the concept that the social deficits 
were not confounded by the locomotor hyperactivity measure. Thus, homecage 
analysis offers the opportunity to directly compare the onset and duration of drug 
effects on different behavioural domains simultaneously in the same group of 
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animals. The findings that the PCP-induced social deficits and the locomotor effects 
have a different time course, suggests that one effect is not secondary to the other. 
It should be noted that other homecage systems exist with the capacity to monitor 
social activity. For example, Shemesh and colleagues (2014) developed a technology 
capable of discriminating interactions between three or more fluorescently labelled 
mice over several consecutive dark phases.  
Implications for 3Rs and Drug discovery 
Traditional behavioural paradigms typically require large numbers of rodents to 
compensate for unavoidable variability in behaviour associated with environmental 
perturbations and handling. With the approach described here, data is collected 
within the homecage environment with minimal disturbance thereby potentially 
increasing between-laboratory reproducibility and reducing the number of animals 
required. While using a homecage monitoring approach satisfies the “reduction” 
element of the 3Rs, some sources of variability (e.g. inter-animal differences) are 
unavoidable and therefore, a certain number of animals will always be required to 
ensure studies are sufficiently powered. 
Furthermore, a range of behaviours can be monitored simultaneously therefore 
reducing the requirement of animals to undergo multiple test batteries, thereby 
addressing the ‘refinement’ element of the 3Rs. From a drug discovery perspective, 
there is an opportunity to reveal the onset and duration of differential drug effects 
on distinct behaviours in the same animals simultaneously. As well as providing a 
richer data set, this also enables possible confounds of one behavioural effect upon 
another to be revealed. Additionally, since a large quantity of longitudinal data is 
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acquired which increases statistical power, fewer rodents may be required to detect 
drug effects.  
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Figure Legends  
Figure 1. Effect of acute PCP administration on automatically- derived locomotor 
activity. Activity data from a randomly selected rat presented as raster plots of the sum of 
distance travelled (mm) in 5 min time bins over 24 h following saline (a) and PCP (b) 
administration. Mean distance travelled presented in 15 min bins across 24 h post-treatment (c).  
Dotted lines represent the SEM. Graphs (d), (e), (f) correspond to the regions highlighted by blue 
bars in (c). *p<0.05 (ANOVA), #p<0.05, ##p<0.01, ####p<0.0001 (post-hoc Fisher test). N = 15 per 
group. 
17 
 
 
Figure 2. Effect of acute PCP administration on automatically derived social 
activity. Time spent isolated (> 200 mm) from all cage-mates (s) presented in 15 min bins across 
24 h post treatment (a). Dotted lines represent the SEM. Graphs (b), (c), (d) correspond to the 
regions highlighted by blue bars in (a). **p<0.01, ***p<0.001 (ANOVA), #p<0.05, ##p<0.01 (post-hoc 
Fisher test). N = 15 per group. Data represent mean ± SEM. 
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